Postdoctoral Researcher, Pain Research, Industrial Postdoctoral Programme
About this role
Job Description
Shape the Future of Drug Discovery and Development
At Orion Pharma, we believe that scientific breakthroughs are built through strong collaboration between academia and industry. The Industrial Postdoctoral Program offers an exceptional opportunity for early-career researchers to apply their scientific expertise to real-world challenges within a leading pharmaceutical company.
As a Postdoctoral Researcher, you will work at the interface of cutting-edge academic research and industrial innovation, contributing to projects with the potential to advance drug discovery, development, and patient care.
Orion's Pain Therapy Unit is offering the following postdoctoral research opportunities, each focused on generating novel insights and technologies to support the development of future pain therapies.
Computational Discovery of Next-Generation Chronic Pain Targets
This project leverages large-scale transcriptomic and proteomic datasets to uncover the biological drivers of chronic pain and identify promising new therapeutic targets. The postdoctoral researcher will integrate and analyze public and proprietary omics data to generate actionable insights that support target validation, prioritization, and the discovery of next-generation pain therapies.
Physics-Based Prediction of Membrane Permeability for Beyond-Rule-of-Five Compounds
This project focuses on advancing computational drug design by developing predictive models for the membrane permeability of complex beyond-rule-of-five (bRo5) molecules. The postdoctoral researcher will combine molecular dynamics simulations with advanced sampling techniques to better understand permeation mechanisms and improve the prediction of drug-like properties in challenging chemical spaces.
Translational Neuro-Inflammation Pharmacology for Pain Programs
This project aims to strengthen the understanding of neuro-inflammation as a key contributor to chronic pain and translate this knowledge into drug development